Gabriel Frizzo Ramos

Gabriel Frizzo Ramos

Auto-generated profile, based on publicly available information

Gabriel Frizzo Ramos

Hospital Municipal da Vila Santa Catarina Dr. Gilson de Cássia Marques de Carvalho; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Jornal de Pediatria
Verified
Journal Article
Open access
GRGabriel F. Ramos
Gabriel F. Ramos
VRVanessa P. Ribeiro
Vanessa P. Ribeiro
MMMariana P. Mercadante
Mariana P. Mercadante
MRMaira P. Ribeiro
Maira P. Ribeiro
ADArtur F. Delgado
Artur F. Delgado
CSClovis A. Silva
Clovis A. Silva
To evaluate mortality in adolescents and young adult patients with chronic diseases followed in a Latin American tertiary hospital. A cross-sectional retrospective study was performed in a tertiary/academic hospital in the state of São Paulo, Brazil. Death occurred in 529/2850 (18.5%) adolescents and young adult patients with chronic diseases, and 25/529 (4.7%) were excluded due to incomplete medical charts. Therefore, 504 deaths were evaluated. Deaths occurred in 316/504 (63%) of early adolescent patients and in 188/504 (37%) of late adolescent/young adult patients. Further comparisons between early adolescents (n=316) and late adolescent/young adult patients (n=188) with pediatric chronic diseases at the last hospitalization showed that the median disease duration (22.0 [0-173] vs. 43.0 [0-227] months, p<0.001) was significantly lower in early adolescents vs. late adolescent/young adult patients. The median number of previous hospitalizations was significantly lower in the former group (4.0 [1-45] vs. 6.0 [1-52], p<0.001), whereas the last hospitalization in intensive care unit was significantly higher (60% vs. 47%, p=0.003). Regarding supportive measures, palliative care was significantly lower in the younger group compared to the older group (33% vs. 43%, p=0.02). The frequencies of renal replacement therapy (22% vs. 13%, p=0.02), vasoactive agents (65% vs. 54%, p=0.01), and transfusion of blood products (75% vs. 66%, p=0.03) were significantly higher in the younger group. The five most important etiologies of pediatric chronic diseases were: neoplasias (54.2%), hepatic diseases/transplantation (10%), human immunodeficiency virus (5.9%), and childhood-onset systemic lupus erythematosus and juvenile idiopathic arthritis (4.9%). Autopsy was performed in 58/504 (11%), and discordance between clinical and postmortem diagnoses was evidenced in 24/58 (41.3%). Almost 20% of deaths occurred in adolescents and young adults with distinct supportive care and severe disease patterns. Discordance between clinical diagnosis and autopsy was frequently observed.

1 January 2020 in Clinics
Verified
Journal Article
Open access
PDF file
JCJorge David Aivazoglou Carneiro
Jorge David Aivazoglou Carneiro
GRGabriel Frizzo Ramos
Gabriel Frizzo Ramos
WCWerther Brunow de Carvalho
Werther Brunow de Carvalho
CJCíntia Johnston
Cíntia Johnston
ADArtur Figueiredo Delgado
Artur Figueiredo Delgado
Hemostasis in children and adolescents: ontogenetic characteristics and impact on pediatric thromboembolism During phylogenetic evolution, living beings develop a regulatory hemostatic system for protecting the cardiovascular system. In humans, the hemostatic system has a peculiar ontogenesis, which consists of a dynamic evolutionary process deeply influenced by age. The term “developmental hemostasis” has been used since the 1990s to describe age-dependent changes in the hemostatic system, as seen in (). Children are physiologically protected from thromboembolic events due to a decreased [...] Hemostasis in children and adolescents: ontogenetic characteristics and impact on pediatric thromboembolism During phylogenetic evolution, living beings develop a regulatory hemostatic system for protecting the cardiovascular system. In humans, the hemostatic system has a peculiar ontogenesis, which consists of a dynamic evolutionary process deeply influenced by age. The term “developmental hemostasis” has been used since the 1990s to describe age-dependent changes in the hemostatic system, as seen in (). Children are physiologically protected from thromboembolic events due to a decreased

1 November 2019 in Jornal de Pediatria (Versão em Português)
Verified
Journal Article
Open access
GRGabriel F. Ramos
Gabriel F. Ramos
VRVanessa P. Ribeiro
Vanessa P. Ribeiro
MMMariana P. Mercadante
Mariana P. Mercadante
MRMaira P. Ribeiro
Maira P. Ribeiro
ADArtur F. Delgado
Artur F. Delgado
CSClovis A. Silva
Clovis A. Silva

7 April 2025 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
FKFelipe Krakauer
Felipe Krakauer
RPRaquel Pissiguelli
Raquel Pissiguelli
MMMarina Moranduzzo
Marina Moranduzzo
BTBruna Marques Tofaneto
Bruna Marques Tofaneto
SCSophia Bastos Correa da Costa
Sophia Bastos Correa da Costa
LBLuisa Zagne Braz
Luisa Zagne Braz
Chryseobacterium indologenes is a Gram-negative aerobic bacillus commonly found in nosocomial environments, particularly in patients with prolonged hospital stays or those requiring long-term invasive devices. It primarily affects elderly and immunocompromised individuals. This microorganism is associated with multidrug resistance, which is a crucial factor in treatment decisions. Here, we report a case of C. indologenes infection in an infant following the ingestion of milk formula diluted with untreated water. Chryseobacterium indologenes sepsis in a pediatric patient